Pr Mahasti Saghatchian

Specialty

Oncologist, breast expert

Title

Head of service

Hospital

Hôpital Américain (Paris)

Latest articles

• Creation of a tool to evaluate supportive care. (Aug 1, 2024)
• Leveraging G-CSF prescribing in the outpatient setting: considerations beyond clinical factors-a questionnaire study. (May 14, 2024)
• Trastuzumab deruxtecan in previously treated HER2-positive metastatic or unresectable breast cancer: Real-life data from the temporary use authorization program in France. (May 1, 2024)
• Real-World Impact of Adjuvant Anti-HER2 Treatment on Characteristics and Outcomes of Women With HER2-Positive Metastatic Breast Cancer in the ESME Program. (Oct 3, 2023)
• [Adapted physical activity and metastatic cancer: What needs and expectations?]. (Dec 1, 2022)